Doximity (DOCS) Set to Announce Earnings on Thursday

Doximity (NASDAQ:DOCS) is set to release its earnings data after the market closes on Thursday, August 8th. Analysts expect Doximity to post earnings of $0.22 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.Persons interested in registering for the company’s earnings conference call can do so using this link.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, May 16th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Doximity had a net margin of 31.04% and a return on equity of 17.44%. The company had revenue of $118.06 million for the quarter, compared to analysts’ expectations of $116.46 million. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Stock Performance

NASDAQ:DOCS opened at $26.24 on Wednesday. Doximity has a fifty-two week low of $19.71 and a fifty-two week high of $34.56. The company has a 50 day moving average price of $27.95 and a 200 day moving average price of $27.35. The stock has a market capitalization of $4.87 billion, a P/E ratio of 36.44, a PEG ratio of 5.12 and a beta of 1.22.

Analysts Set New Price Targets

Several equities analysts have commented on DOCS shares. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price target for the company in a research report on Thursday, April 25th. William Blair reiterated an “outperform” rating on shares of Doximity in a report on Friday, May 17th. Morgan Stanley restated an “underweight” rating and set a $25.00 price target on shares of Doximity in a report on Tuesday, April 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Doximity in a research note on Friday, May 17th. Finally, Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Doximity has a consensus rating of “Hold” and an average target price of $28.00.

Insider Buying and Selling at Doximity

In related news, insider Craig Overpeck sold 1,500 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total transaction of $35,775.00. Following the completion of the sale, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Craig Overpeck sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total transaction of $35,775.00. Following the completion of the transaction, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the sale, the director now owns 11,258 shares in the company, valued at $287,529.32. The disclosure for this sale can be found here. Insiders have sold a total of 51,951 shares of company stock worth $1,524,843 over the last 90 days. Insiders own 39.40% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.